I continue to emphasize this experimental drug is being used by biohackers and my protocols are not FDA approved. People should use caution with any substance, supplement or peptide and always consult with their physician.
"However, despite its promise, there are important clinical considerations. Retatrutide is not yet FDA-approved, and thus remains officially an investigational therapy. As such, patients and healthcare providers must approach its use with caution and awareness of the regulatory landscape. Currently, some compounding pharmacies have already begun producing and marketing Retatrutide in compounded peptide formulations. This raises significant safety concerns, as compounded medications lack the rigorous quality control, purity testing, and oversight mandated for FDA-approved pharmaceutical preparations. Risks associated with these compounded forms include contamination, dosing inconsistencies, incorrect formulations, and potentially serious adverse effects due to unvalidated manufacturing processes. The FDA has specifically cautioned against the widespread and uncontrolled use of compounded GLP-1 medications, underscoring the potential dangers inherent in using medications from sources not subject to stringent regulatory standards." This is directly in the post. Feel free to subscribe and read the full detail.
Larazotide, BPC157 and KPV should be the foundation of any peptide protocol for gut healing.
Cynthia really nailed this
I continue to emphasize this experimental drug is being used by biohackers and my protocols are not FDA approved. People should use caution with any substance, supplement or peptide and always consult with their physician.
"However, despite its promise, there are important clinical considerations. Retatrutide is not yet FDA-approved, and thus remains officially an investigational therapy. As such, patients and healthcare providers must approach its use with caution and awareness of the regulatory landscape. Currently, some compounding pharmacies have already begun producing and marketing Retatrutide in compounded peptide formulations. This raises significant safety concerns, as compounded medications lack the rigorous quality control, purity testing, and oversight mandated for FDA-approved pharmaceutical preparations. Risks associated with these compounded forms include contamination, dosing inconsistencies, incorrect formulations, and potentially serious adverse effects due to unvalidated manufacturing processes. The FDA has specifically cautioned against the widespread and uncontrolled use of compounded GLP-1 medications, underscoring the potential dangers inherent in using medications from sources not subject to stringent regulatory standards." This is directly in the post. Feel free to subscribe and read the full detail.